- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Gland Pharma Limited — Updates, 29-07-2026: Press Release
29-07-2026 | 11:37 am
29-07-2026 | 11:37 am
Gland Pharma received USFDA approval for Sugammadex Injection and launched it immediately. This product targets a US market with annual sales of approximately USD 1.6 billion.
No comments yet. Be the first to comment!